← The Wire
OGNNYSE
Organon & Co.
Pharmaceutical Preparations · CIK 1821825
Organon & Co. develops, manufactures, and markets women's health products, biosimilars, and established medicines
red 8-K · 90d
$3.53B
Market cap
$13.55
Last close
+0.4%
1D
+1.1%
5D
1.4M
Volume
Price · last 39 sessions+2.2%
May 4L $13.26 · H $13.55Jun 29
90
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
SC 13GSCHEDULE 13GFeb 13, 2023SC 13GSC 13GFeb 10, 2023SC 13GSC 13GFeb 4, 2022SC 13GSCHEDULE 13GJul 12, 2021
Insider Activity
In the 90 days to Nov 12, 2025: 1 insider bought $502K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2025 | Cox Carrie SmithExecutive Chair | Buy | 65,400 | $7.67 | $502K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance